1887

Abstract

SUMMARY

The antigenic specificities of the membrane antigen (MA) complex on three Epstein—Barr (EB) virus-producing cell lines have been compared by complete absorption of an anti-MA antiserum with P3HR-1 cells, followed by testing for residual anti-MA antibody activity against B95-8 and QIMR-WIL cells. Indirect membrane immunofluorescence showed that the absorbed serum, which had lost the capacity to bind P3HR-1 cells, nevertheless gave bright staining on a small proportion of B95-8 cells. SDS-polyacrylamide gel electrophoretic analysis of I-labelled MA polypeptides showed that the absorbed serum was able to isolate MA polypeptides from both B95-8 and QIMR-WIL cells, but not from P3HR-1 cells. The results demonstrate that there is substantial sharing of antigenic specificities between the MA determined by three isolates of EB virus, and some antigenic divergence.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-53-2-371
1981-04-01
2022-01-21
Loading full text...

Full text loading...

/deliver/fulltext/jgv/53/2/JV0530020371.html?itemId=/content/journal/jgv/10.1099/0022-1317-53-2-371&mimeType=html&fmt=ahah

References

  1. Adams A., Bjursell G., Gussander E., Koliais S., Falk L., Lindahl T. 1979; Size of the intracellular circular Epstein-Barr virus DNA molecules in infectious mononucleosis-derived human lymphoid cell lines. Journal of Virology 29:815–817
    [Google Scholar]
  2. Bornkamm G. W., Delius H., Zimber U., Hudewentz J., Epstein M. A. 1980; Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs. Journal of Virology 35:603–618
    [Google Scholar]
  3. Delius H., Bornkamm G. W. 1978; Heterogeneity of Epstein-Barr virus. III. Comparison of a transforming and a non-transforming virus by partial denaturation mapping of their DNAs. Journal of Virology 27:81–89
    [Google Scholar]
  4. De Eschryver A., Klein G., Hewetson J., Rocchi G., Henle W., Henle G., Moss D. J., Pope J. H. 1974; Comparison of EBV neutralization tests based on abortive infection or transformation of lymphoid cells and their relation to membrane reactive antibodies (anti MA). International Journal of Cancer 13:353–362
    [Google Scholar]
  5. Fialkow P. J. 1976; Clonal origin of human tumours. Biochimica et Biophysica Acta 458:283–321
    [Google Scholar]
  6. Gerber P., Whang-Peng J., Monroe J. H. 1969; Transformation and chromosome changes induced by Epstein-Barr virus in normal human leukocyte cultures. Proceedings of the National Academy of Sciences of the United States of America 63:740–747
    [Google Scholar]
  7. Gerber P., Nkrumah F. K., Pritchett R., Kieff E. 1976; Comparative studies of Epstein-Barr virus strains from Ghana and the United States. International Journal of Cancer 17:71–81
    [Google Scholar]
  8. Gergely L., Klein G., Ernberg I. 1971; Appearance of Epstein-Barr virus-associated antigens in infected Raji cells. Virology 45:10–21
    [Google Scholar]
  9. Given D., Kieff E. 1978; DNA of Epstein-Barr virus. IV. Linkage map of restriction enzyme fragments of the B95-8 and W91 strains of Epstein-Barr virus. Journal of Virology 28:524–542
    [Google Scholar]
  10. Henle W., Diehl V., Kohn G., Zur Hausen H., Henle G. 1967; Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science 157:1064–1065
    [Google Scholar]
  11. Hoffman G. J., Lazarowitz S. G., Hayward S. D. 1980; Monoclonal antibody against a 250000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralising antigen. Proceedings of the National Academy of Sciences of the United States of America 77:2979–2983
    [Google Scholar]
  12. Kaschka-Dierich C., Falk L., Bjursell G., Adams A., Lindahl T. 1977; Human lymphoblastoid cell lines derived from individuals without lymphoproliferative disease contain the same latent forms of Epstein-Barr virus DNA as those found in tumor cells. International Journal of Cancer 20:173–180
    [Google Scholar]
  13. Kawai Y., Nonoyama M., Pagano J. S. 1973; Reassociation kinetics for Epstein-Barr virus DNA: nonhomology to mammalian DNA and homology of viral DNA in various diseases. Journal of Virology 12:1006–1012
    [Google Scholar]
  14. Kieff E., Levine J. 1974; Homology between Burkitt herpes viral DNA and DNA in continuous lymphoblastoid cells from patients with infectious mononucleosis. Proceedings of the National Academy of Sciences of the United States of America 71:355–358
    [Google Scholar]
  15. Klein G., Klein E., Clifford P. 1967; Search for host defences in Burkitt lymphoma: membrane immunofluorescence tests on biopsies and tissue culture lines. Cancer Research 27:2510–2520
    [Google Scholar]
  16. Klein G., Pearson G., Henle G., Henle W., Goldstein G., Clifford P. 1969; Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. III. Comparison of blocking of direct membrane immunofluorescence and anti-EBV reactivities of different sera. Journal of Experimental Medicine 129:697–705
    [Google Scholar]
  17. Menezes J., Leibold W., Klein G. 1975; Biological differences between Epstein-Barr virus (EBV) strains with regard to lymphocyte transforming ability, superinfection and antigen induction. Experimental Cell Research 92:478–484
    [Google Scholar]
  18. Miller G., Shope T., Lisco H., Stitt D., Lipman M. 1972; Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. Proceedings of the National Academy of Sciences of the United States of America 69:383–387
    [Google Scholar]
  19. Miller G., Robinson J., Heston L., Lipman M. 1974; Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference. Proceedings of the National Academy of Sciences of the United States of America 71:4006–4010
    [Google Scholar]
  20. Miller G., Coope D., Niederman J., Pagano J. 1976; Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis-derived strains of Epstein-Barr virus released from transformed marmoset cells. Journal of Virology 18:1071–1080
    [Google Scholar]
  21. Nonoyama M., Pagano J. S. 1973; Homology between Epstein-Barr virus DNA and viral DNA from Burkitt’s lymphoma and nasopharyngeal carcinoma determined by DNA-DNA reassociation kinetics. Nature, London 242:44–47
    [Google Scholar]
  22. North J. R., Morgan A. J., Epstein M. A. 1980; Observations on the EB virus envelope and virus-determined membrane antigen (MA) polypeptides. International Journal of Cancer 26:231–240
    [Google Scholar]
  23. Pagano J. S., Huang C-H, Huang Y-T. 1976; Epstein-Barr virus genome in infectious mononucleosis. Nature, London 263:787–789
    [Google Scholar]
  24. Pearson G., Dewey F., Klein G., Henle G., Henle W. 1970; Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens induced by the virus. Journal of the National Cancer Institute 45:989–995
    [Google Scholar]
  25. Pearson G., Henle G., Henle W. 1971; Production of antigens associated with Epstein-Barr virus in experimentally infected lymphoblastoid cell lines. Journal of the National Cancer Institute 46:1243–1250
    [Google Scholar]
  26. Pope J. H. 1968; Establishment of cell lines from Australian leukaemic patients: presence of a herpes-like virus. Australian Journal of Experimental Biology and Medical Science 46:643–645
    [Google Scholar]
  27. Qualtiere L. F., Pearson G. R. 1979; Epstein-Barr virus-induced membrane antigens: immunochemical characterisation of Triton X100 solubilized viral membrane antigens from EBV-superinfected Raji cells. International Journal of Cancer 23:808–817
    [Google Scholar]
  28. Qualtiere L. F., Pearson G. R. 1980; Radioimmune precipitation study comparing the Epstein-Barr virus membrane antigens expressed on P3HR-1 virus-superinfected Raji cells to those expressed on cells in a B95-8 virus-transformed producer culture activated with tumor-promoting agent (TPA). Virology 102:360–369
    [Google Scholar]
  29. Raab-Traub N., Pritchett R., Kieff E. 1978; DNA of Epstein-Barr virus. III. Identification of restriction enzyme fragments that contain DNA sequences which differ among strains of Epstein-Barr virus. Journal of Virology 27:388–398
    [Google Scholar]
  30. Rymo L., Lindahl T., Adams A. 1979; Sites of sequence variability in Epstein-Barr virus DNA from different sources. Proceedings of the National Academy of Sciences of the United States of America 76:2794–2798
    [Google Scholar]
  31. Silvestre D., Ernberg I., Neauport-Sautes C., Kourilsky F. M., Klein G. 1974; Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein-Barr virus. II. Immunoelectron microscopy. Journal of the National Cancer Institute 53:67–74
    [Google Scholar]
  32. Strnad B. C., Neubauer R. H., Rabin H., Mazur R. A. 1979; Correlation between Epstein-Barr virus membrane antigen and three large cell surface glycoproteins. Journal of Virology 32:885–894
    [Google Scholar]
  33. Sugden B. 1977; Comparison of Epstein-Barr viral DNAs in Burkitt lymphoma biopsy cells and in cells clonally transformed in vitro . Proceedings of the National Academy of Sciences of the United States of America 74:4651–4655
    [Google Scholar]
  34. Svedmyr A., Demissie A., Klein G., Clifford P. 1970; Antibody patterns in different human sera against intracellular and membrane-antigen complexes associated with Epstein-Barr virus. Journal of the National Cancer Institute 44:595–610
    [Google Scholar]
  35. Thorley-Lawson D. A., Edson C. M. 1979; The polypeptides of the Epstein-Barr virus membrane antigen complex. Journal of Virology 32:458–467
    [Google Scholar]
  36. Thorley-Lawson D. A., Geilinger K. 1980; Monoclonal antibodies against the major glycoprotein (gp 350/220) of Epstein-Barr virus neutralise infectivity. Proceedings of the National Academy of Sciences of the United States of America 77:5307–5311
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-53-2-371
Loading
/content/journal/jgv/10.1099/0022-1317-53-2-371
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error